STX18

Syntaxin-18 · Q9P2W9 · STX18 on Sugi Atlas →

0 patent compounds predicted against STX18, 0 high-confidence (nearest known ligand ≥ 0.5)

Top predicted compounds (top 20 by supporting neighbours, then confidence)

CompoundConfidenceSupporting neighbours

Clinical trials — most relevant to STX18 by text similarity (a relevance ranking, not an exhaustive list)

TrialPhaseStatus
Evaluate the Efficacy and Safety of GZR18 Injection in Obese Subjects With Obstructive Sleep Apnea Receiving Positive Airway Pressure (PAP) Therapy PHASE3NOT_YET_RECRUITING
Prehospital Early Administration of Ketamine for Status Epilepticus in Epileptic Kids (PEAK-SEEK) PHASE2/PHASE3RECRUITING
Evaluate the Efficacy and Safety of GZR18 Injection in Obese Subjects With Obstructive Sleep Apnea Not Treated With Positive Airway Pressure (PAP) Therapy PHASE3NOT_YET_RECRUITING
A Study to Assess the Tolerability of a Single Dose of STX107 in Adults With Fragile X Syndrome PHASE2SUSPENDED
A Phase 2a Efficacy, Safety, Tolerability, and PK Study of SYT-510 in Participants With Generalized Anxiety Disorder PHASE2RECRUITING
Modulate Cellular Stress in the Immune Cells to Reduce Rate of Symptomatic Viral Infection PHASE2COMPLETED
Safety, Reactogenicity, and Immunogenicity Trial of STX-S SARS-CoV-2 Vaccine in Adults PHASE1COMPLETED
To Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of GB18 Injection in Healthy Participants PHASE1RECRUITING
A Study to Evaluate Satety, Tolerability, Biodistribution, Radiation Dosimetry, and Pharmacokinetics of SST001 in Healthy Volunteers, Patients With PD and Patients With MSA PHASE1NOT_YET_RECRUITING
Safety, Tolerability and Pharmacodynamics of SYNB1353 in Healthy Adult Volunteers PHASE1COMPLETED
A Phase 1 Study of STX-0712 in Patients With Advanced Hematological Malignancies (CMML and AML) PHASE1RECRUITING
Nilotinib in Huntington's Disease PHASE1UNKNOWN
A Phase 1 Single Dose and Multiple Ascending Dose Study to Assess the Relative Bioavailability, Food Effect, Safety, Tolerability and Pharmacokinetics of SYT-510 in Healthy Participants PHASE1COMPLETED
Phase 1 Trial of the TQB2928 Injection in Patients With Advanced Cancers PHASE1UNKNOWN
Phenylbutyrate for Monogenetic Developmental and Epileptic Encephalopathy EARLY_PHASE1ACTIVE_NOT_RECRUITING
MEG Study of Acute STX209 Effects in ASD EARLY_PHASE1COMPLETED
A Multicentric European Study to Promote Clinical Trial Readiness for STXBP1-related Disorders nanRECRUITING
STXBP1 and SYNGAP1 Related Disorders Natural History Study nanRECRUITING
Natural History Study in Pediatric Patients with STXBP1 Encephalopathy with Epilepsy nanWITHDRAWN
Phenotyping and Identification of Biological Markers in STXBP1 Encephalopathy nanNOT_YET_RECRUITING
Azithromycin in Post Diarrheal Haemolytic and Uremic Syndrome nanCOMPLETED
Natural History Study of SLC25A46 Mutation-related Mitochondriopathy nanCOMPLETED
Gene-STEPS: Shortening Time of Evaluation in Paediatric Epilepsy Services nanUNKNOWN
Genetics of Endocrine Tumours - Familial Isolated Pituitary Adenoma - FIPA nanRECRUITING
Comparing Outcomes of Theta Burst Stimulation in Depression Using Advanced PET Imaging nanNOT_YET_RECRUITING
Impact of Sulphonylureas on Neurodevelopmental Outcomes in KCNJ11-related Intermediate Developmental Delay, Epilepsy and Neonatal Diabetes (iDEND) Syndrome nanRECRUITING
Polycystic Ovary Syndrome in Type 1 Diabetes nanNOT_YET_RECRUITING
Transcriptomic Profile of Patients Treated With Different Modalities of Spinal Cord Stimulation nanUNKNOWN
Study of the Genetic Factors Involved in Autism and Related Disorders nanRECRUITING
Role of Neurotransmission and Functional CNS Networks in Spasmodic Dysphonia nanCOMPLETED

Related proteins — ESM-2 sequence neighbours (a STX18 binder may also engage these)

ProteinNameSimilarity
Q5REB4 1.000 Q5REB4 →
Q8VDS8 1.000 Q8VDS8 →
Q68FW4 1.000 Q68FW4 →
Q4VBI7 0.999 Q4VBI7 →
Q7ZTY7 0.979 Q7ZTY7 →
Q9ZPV9 0.975 Q9ZPV9 →
Q9CQ56 0.974 Q9CQ56 →
Q8C0M0 0.972 Q8C0M0 →
O54924 0.972 O54924 →
Q12981 0.971 Q12981 →
Q9LRP1 0.971 Q9LRP1 →
Q24509 0.971 Q24509 →
Q9JJA2 0.971 Q9JJA2 →
USE1 Vesicle transport protein USE1 0.971 landscape →
Q12846 0.971 Q12846 →
Q8VHI8 0.970 Q8VHI8 →
O94531 0.970 O94531 →
Q20797 0.970 Q20797 →
Q9LK09 0.970 Q9LK09 →
Q9LNC6 0.969 Q9LNC6 →
Q9D0I4 0.969 Q9D0I4 →
A5D796 0.969 A5D796 →
Q6ZWJ1 0.968 Q6ZWJ1 →
Q9VE50 0.968 Q9VE50 →
Q6PGF7 0.968 Q6PGF7 →
P59277 0.968 P59277 →
Q9NWB7 0.968 Q9NWB7 →
Q91WS7 0.968 Q91WS7 →
Q7ZTQ5 0.968 Q7ZTQ5 →
Q5ZLG9 0.968 Q5ZLG9 →